OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Clinical trials for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS explained in plain language.
Never miss a new study
Get alerted when new OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS trials appear
Sign up with your email to follow new studies for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise may soothe Chemo's nerve pain, new trial hopes
Symptom relief Not yet recruitingThis study tests whether exercise can reduce nerve damage caused by chemotherapy drugs like oxaliplatin and paclitaxel. About 140 people with colorectal or gynecologic cancer will either exercise or receive usual care. Researchers will check nerve function, blood markers, and qua…
Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Phase: NA • Sponsor: National Cancer Center, Korea • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
New study to measure Chemo's toll on hands in colorectal cancer survivors
Knowledge-focused Not yet recruitingThis study looks at how nerve damage from the chemotherapy drug oxaliplatin affects hand function, grip strength, and quality of life in people with colorectal cancer. Researchers will measure hand strength and dexterity in 84 patients who have received at least 3 cycles of oxali…
Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Simple blood test may predict chemo nerve damage before it starts
Knowledge-focused Not yet recruitingThis study aims to find blood markers that can predict if a person will develop nerve pain from certain chemotherapy drugs (taxanes or oxaliplatin). Researchers will collect blood samples and check nerve function over 6 months in 192 cancer patients. The goal is to use this infor…
Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Sponsor: Centre Hospitalier de Bligny • Aim: Knowledge-focused
Last updated May 05, 2026 11:54 UTC